| Autor: |
Longo-Mbenza, Benjamin, Mashi, Murielle Longokolo, Tshikwela, Michel Lelo, Mokondjimobe, Etienne, Gombet, Thierry, Ellenga-Mbolla, Bertrand, Okwe, Augustin Nge, Kabangu, Nelly Kangola, Fuele, Simon Mbungu |
| Předmět: |
|
| Zdroj: |
ISRN Cardiology; 2011, Special section p1-5, 5p |
| Abstrakt: |
Background and Purpose. It now appears clear that both HIV/AIDS and antiretroviral therapy (HAART) use are associated with higher risk of cardiovascular disease such as stroke. In this study, we evaluated the prevalence, the risk factors, and the cardiometabolic comorbidities of stroke in HIV/AIDS Central African patients. Methods. This hospital-based cross-sectional study collected clinical, laboratory, and imaging data of black Central African heterosexual, intravenous drug nonuser, and HIV/AIDS patients. Results. There were 54 men and 62 women, with a female to male ratio of 1.2 : 1. All were defined by hypercoagulability and oxidative stress. Hemorrhagic stroke was reported in 1 patient, ischemic stroke in 17 patients, and all stroke subtypes in 18 patients (15%). Younger age <45years (P = .003),autoimmunity (P < .0001), and metabolic syndrome defined by IDF criteria (P <.0001) were associated with ischemic stroke. Conclusions. Clustering of several cardiometabolic factors, autoimmunity, oxidative stress, and lifestyle changes may explain accelerated atherosclerosis and high risk of stroke in these young black Africans with HIV/AIDS. Prevention and intervention programs are needed. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
